Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025

Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025

  • QYResearch
  • October 2018
  • Pharmaceutical
  • 112 pages

Report Description

1
1
This report studies the global market size of Flu Vaccine (Influenza Vaccine) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Flu Vaccine (Influenza Vaccine) in these regions.
This research report categorizes the global Flu Vaccine (Influenza Vaccine) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
In 2017, the global Flu Vaccine (Influenza Vaccine) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Flu Vaccine (Influenza Vaccine) market based on company, product type, application and key regions.

The various contributors involved in the value chain of Flu Vaccine (Influenza Vaccine) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Flu Vaccine (Influenza Vaccine) include
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

Market Size Split by Type
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Market Size Split by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Flu Vaccine (Influenza Vaccine) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Flu Vaccine (Influenza Vaccine) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Flu Vaccine (Influenza Vaccine) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Flu Vaccine (Influenza Vaccine) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Flu Vaccine (Influenza Vaccine) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Flu Vaccine (Influenza Vaccine) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Flu Vaccine (Influenza Vaccine) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Have query on this report?

Make an Enquiry
Table of Contents
1 Study Coverage
1.1 Flu Vaccine (Influenza Vaccine) Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
List of Tables and Figures
Figure Picture of Flu Vaccine (Influenza Vaccine)
Figure Global Flu Vaccine (Influenza Vaccine) Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Flu Vaccine (Influenza Vaccine) Production Market Share by Types (Product Category) in 2017
Figure Whole Virus Vaccines Product Picture
Table Major Manufacturers of Whole Virus Vaccines

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074